Generic Drugs Related Topics 
Bio Pharma Dive
AUGUST 25, 2022
After reviewing multiple options including a possible sale, the Swiss drugmaker said spinning off Sandoz would give the division “greater freedom to operate” and capitalize on newly growing sales
Bio Pharma Dive
JULY 19, 2022
The pharmaceutical company is considering selling or splitting off its struggling Sandoz division and expects to give an update by the end of the year
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
JUNE 22, 2022
In the video below, I discuss how generic drug pricing and the rise of patient-paid, discount card prescriptions pose a risk to pharmacy benefit plans and the PBM business. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
Drug Patent Watch
JUNE 8, 2021
When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without drug price regulations, the pricing is based largely on profitability.….
Drug Patent Watch
OCTOBER 6, 2020
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry….
NY Times
SEPTEMBER 18, 2021
Drugs (Pharmaceuticals) Factories and Manufacturing Generic Brands and Products Shortages Layoffs and Job Reductions International Trade and World Market
BioSpace
JANUARY 14, 2021
Billionaire entrepreneur Mark Cuban, best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank,” is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company
Drug Patent Watch
OCTOBER 12, 2021
International License Abstract Development of generic drug product…. The post Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review appeared first on DrugPatentWatch - Make Better Decisions.
The Pharma Data
MAY 5, 2021
FDA officials said that the number of a product specific guidances (PSGs) issued by the Office of Generic Drugs (OGD) has increased steadily since FY 2013. FDA webinar on product specific guidance for generic drugs .
Scienmag
JUNE 20, 2022
billion by purchasing generic drugs at Mark Cuban prices Abstract: [link] URL goes live when the embargo lifts A brief research report found that Medicare could have saved up to $3.6 billion by purchasing generic drugs at the same prices as the Mark Cuban Cost Plus Drug […]. Latest News billion Cuban Drugs generic mark Medicare prices purchasing saveMedicare could save up to $3.6
Drug Patent Watch
AUGUST 12, 2020
Just because a drug has received FDA approval does not mean that it is available in the marketplace. The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market appeared first on DrugPatentWatch - Make Better Decisions.
BioTech 365
MARCH 28, 2022
Global Generic Drugs Market Report 2022: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2027 – ResearchAndMarkets.com Global Generic Drugs Market Report 2022: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2027 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Generic Drugs Market: Global … Continue reading → Business Wire
Drug Patent Watch
SEPTEMBER 15, 2020
This likely means fewer generic entrants and less opportunities for consumers to enjoy…. The post Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
FEBRUARY 28, 2023
I am pleased to report that this month’s Drug Channels news roundup was most definitely not written by ChatGPT. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. The era of artificial-intelligence chatbots has arrived!
BioSpace
NOVEMBER 29, 2020
For the medical industry, China's proposed patent linkage system can be more favorable to generic drug companies than the U.S. The fourth Amendment of the China Patent Law has been deliberated and was passed on October 17, 2020. It will come into force on June 1, 2021. system
Drug Channels
MARCH 7, 2023
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m.
BioTech 365
OCTOBER 4, 2021
Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com Canada Generic Drug Market Industry Trends, Share, Size, Growth, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Canada Generic Drug Market: Industry Trends, Share, Size, … Continue reading → Business Wire
BioTech 365
MAY 28, 2021
Global Generic Drugs Market Report 2021: The New Generics Era – The Patent Cliff, Types of Generic Drugs, Simple Generics, Super Generics, Biosimilars, ANDA Approvals – ResearchAndMarkets.com Global Generic Drugs Market Report 2021: The New Generics Era – The Patent … Continue reading → Business Wire
BioTech 365
JUNE 25, 2021
GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com GCC Generic Drug Market Trends, Share, Size, Opportunity and Forecasts 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast … Continue reading → Business Wire
BioTech 365
NOVEMBER 18, 2021
Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com Brazil Generic Drug Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Forecast and Opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Brazil Generic … Continue reading → Business Wire
Drug Channels
NOVEMBER 15, 2022
I’ll cover what’s next for PBMs and discount cards during my upcoming live video webinar, Drug Channels Outlook 2023 , on December 16, 2022, from 12:00 p.m. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
BioTech 365
OCTOBER 1, 2021
Regarding Generic Drugs Sandoz Resolves Legacy Federal Government Civil Investigation in the U.S. Regarding Generic Drugs Company previously disclosed settlement agreement in principle and fully provisioned for this resolution Basel, … Continue reading → GlobeNewswireSandoz Resolves Legacy Federal Government Civil Investigation in the U.S.
BioSpace
AUGUST 18, 2020
Two generic anti-inflammatory drugs typically used in asthma treatments are being proposed for use with COVID-19 because of their potential to dampen disease progression and severity
BioTech 365
FEBRUARY 3, 2021
This New Year, SMB Generic Drug Manufacturers Take Back Control with MDH Insight’s Trailblazing EmpowerRM® Pharma Chargeback Software This New Year, SMB Generic Drug Manufacturers Take Back Control with MDH Insight’s Trailblazing EmpowerRM® Pharma Chargeback Software PEMBROKE PINES, Fla.–(BUSINESS
Drug Channels
OCTOBER 18, 2022
The biosimilar boom for provider-administered drugs continues to accelerate. Below, we share our estimates for wholesalers’ gross margins for brand-name, generic, and biosimilar drugs. We then explain the channel dynamics behind biosimilar and generic drugs’ profits.
Pharmacy Checkers
JULY 11, 2019
I’m proud to share that PharmacyChecker has published a white paper that examines prices and availability of newly approved generic drugs. Our report, based on 40 generic medications that were approved from 2017-2018, clearly shows that generic drug approvals often don’t lead to greater affordability or even access here in the U.S. The KHN article concluded that the lack to generic availability in the U.S. generic for 3 of the drugs.
Drug Channels
NOVEMBER 30, 2021
For more on pharmacy’s future, please register for Drug Channels Outlook 2022 , my live video webinar that will air on December 17, 2021. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
BioSpace
JULY 29, 2021
?Kaiser Permanente has reportedly filed a lawsuit against drug maker Merck for allegedly allowing a "pay-for-delay" scheme that cost the former millions of dollars
Drug Channels
FEBRUARY 24, 2022
Celebrate the imminent return of spring with our selection of noteworthy news from around the drug channel. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. 340B Generic Drugs Gross-to-Net Bubble
Drug Patent Watch
OCTOBER 29, 2019
The post Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 appeared first on DrugPatentWatch - Make Better Decisions. This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the….
BioTech 365
APRIL 28, 2021
United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com United States Drug Patent Prices Database 2021: Brand vs. Generic Drug Price Gap, find generic entry opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading → Business Wire
BioTech 365
APRIL 26, 2021
United States Generic Drugs Market Report 2020-2026: Focus on CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Anti-infective & Oncology – ResearchAndMarkets.com United States Generic Drugs Market Report 2020-2026: Focus on CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Anti-infective & Oncology – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … Continue reading → Business Wire
Drug Channels
JUNE 29, 2022
Through the Drug Channels Institute, I strive to provide you with fact-based and balanced coverage—along with links to source materials so you can make up your own mind. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
Drug Channels
DECEMBER 13, 2021
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. d/b/a Drug Channels Institute.
Drug Channels
AUGUST 17, 2021
The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. Consequently, discount cards could become the force that upends PBMs’ pharmacy benefit economics, plan sponsors’ decisions, and the entire generic market. d/b/a Drug Channels Institute.
Drug Channels
DECEMBER 15, 2021
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. I especially enjoyed the cool visualizations of Drug Channels Institute’s industry data. from your friendly neighborhood blogger at Drug Channels.
Drug Channels
MARCH 15, 2022
Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. drug pricing, reimbursement, and dispensing system.
BioTech 365
APRIL 15, 2021
Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, Form, Source, Distribution Channel – ResearchAndMarkets.com Global Generic Drugs (Small Molecule Generics vs Biosimilars) Market Forecast & Opportunities, 2021-2026 by Application, Drug Delivery, … Continue reading → Business Wire
FDA Law Blog
NOVEMBER 16, 2021
5376 that has garnered the greatest amount of attention (at least in the food and drug law world) is TITLE XIII, Subtitle J (Drug Pricing), Part 1 (Lowering Prices Through Fair Drug Price Negotiation), Section 139001 (Providing for Lower Prices for Certain High-Priced Single Source Drugs).
Bio Pharma Dive
OCTOBER 26, 2021
The generic drug unit has struggled in recent years, while Novartis has moved to focus more narrowly on higher-margin branded medicines
Drug Channels
AUGUST 31, 2021
Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing. I especially enjoyed the cool visualizations of Drug Channels Institute’s industry data.
JAMA Internal Medicine
JULY 5, 2021
This cross-sectional study uses 2017 and 2018 Medicare Part D clams to compare the amount Medicare pays for common generic prescriptions in Part D with prices available to patients without insurance at Costco
Expert insights. Personalized for you.
275 
Let's personalize your content